<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lyme Disease - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
            --banner-bg: #fef3c7;
            --banner-border: #f59e0b;
            --banner-text: #92400e;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .notice-banner {
            background: var(--banner-bg);
            color: var(--banner-text);
            border-bottom: 1px solid var(--banner-border);
            padding: 12px 16px;
            text-align: center;
            font-size: 0.95rem;
            cursor: pointer;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .header-dates {
            display: flex;
            flex-wrap: wrap;
            gap: 10px;
            margin-top: 16px;
            padding-top: 12px;
            border-top: 1px solid rgba(255,255,255,0.22);
            position: relative;
        }

        .date-chip {
            display: inline-flex;
            align-items: center;
            gap: 6px;
            background: rgba(255,255,255,0.14);
            border: 1px solid rgba(255,255,255,0.25);
            border-radius: 999px;
            padding: 5px 10px;
            font-size: 0.82rem;
        }

        .date-chip-label {
            font-weight: 600;
            opacity: 0.95;
        }

        .date-chip time {
            font-variant-numeric: tabular-nums;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-location {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-component {
            background: #f0fdf4;
            color: #166534;
        }

        .tag-complex {
            background: #faf5ff;
            color: #7e22ce;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-modifier {
            background: #fee2e2;
            color: #991b1b;
            text-transform: uppercase;
            letter-spacing: 0.02em;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-classification {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-mechanistic {
            background: #dbeafe;
            color: #1e40af;
        }

        .linkout {
            color: inherit;
            margin-left: 6px;
            font-size: 0.75rem;
            text-decoration: none;
            border-bottom: 1px dotted rgba(0, 0, 0, 0.2);
        }

        .classification-category {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .mapping-section {
            margin-bottom: 16px;
        }

        .mapping-item {
            padding: 10px 12px;
            border: 1px solid #e2e8f0;
            border-radius: 8px;
            background: #ffffff;
            margin-bottom: 10px;
        }

        .mapping-title {
            font-size: 0.9rem;
            font-weight: 600;
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
            align-items: baseline;
            margin-bottom: 6px;
        }

        .mapping-label {
            color: var(--text-muted);
            font-weight: 500;
        }

        .mapping-notes {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
        }

        .mapping-tree {
            margin-top: 6px;
            font-size: 0.75rem;
            color: var(--text-muted);
            list-style: none;
            padding-left: 0;
        }

        .mapping-tree li {
            margin: 2px 0;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-source {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            background: #e2e8f0;
            color: #334155;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .evidence-support:hover,
        .evidence-source:hover {
            transform: translateY(-1px);
            box-shadow: 0 4px 10px rgba(0,0,0,0.08);
        }

        .source-HUMAN_CLINICAL { background: #e0f2fe; color: #075985; }
        .source-MODEL_ORGANISM { background: #fef9c3; color: #854d0e; }
        .source-IN_VITRO { background: #ede9fe; color: #5b21b6; }
        .source-COMPUTATIONAL { background: #cffafe; color: #0e7490; }
        .source-OTHER { background: #e5e7eb; color: #374151; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        .findings-section {
            margin-top: 12px;
        }

        .findings-title {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: var(--text-muted);
            margin-bottom: 6px;
        }

        .finding-item {
            padding: 10px 12px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .finding-statement {
            font-weight: 600;
            color: var(--text);
            margin-bottom: 6px;
            line-height: 1.5;
        }

        .finding-supporting {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Definitions */
        .definition-box {
            background: #ecfeff;
            border-left: 4px solid #0ea5e9;
        }
        .definition-box .item-name { color: #0c4a6e; }
        .definition-box .item-desc { color: #075985; }

        /* Inheritance */
        .inheritance-box {
            background: #fef9c3;
            border-left: 4px solid #ca8a04;
        }
        .inheritance-box .item-name { color: #92400e; }
        .inheritance-box .item-desc { color: #92400e; }

        .criteria-block {
            margin-top: 12px;
            padding: 12px;
            border-radius: 8px;
            border: 1px solid #bae6fd;
            background: rgba(255, 255, 255, 0.7);
        }

        .criteria-title {
            font-weight: 600;
            color: #0c4a6e;
            margin-bottom: 6px;
        }

        .criteria-meta {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .criteria-header {
            font-size: 0.75rem;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #0284c7;
            margin-top: 8px;
        }

        .criteria-list {
            margin-left: 18px;
            font-size: 0.9rem;
            line-height: 1.5;
            color: #0f172a;
        }

        .criteria-list li {
            margin-bottom: 6px;
        }

        .criteria-detail {
            display: block;
            font-size: 0.85rem;
            color: var(--text-muted);
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Histopathology */
        .histopathology-box {
            background: #fff7ed;
            border-left: 4px solid #fb923c;
        }
        .histopathology-box .item-name { color: #9a3412; }
        .histopathology-box .item-desc { color: #c2410c; }

        .histopathology-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #ffedd5;
            color: #c2410c;
        }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Phenotype TOC strip */
        .pheno-toc {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #e2e8f0;
            margin-bottom: 4px;
        }

        .pheno-toc-pill {
            display: inline-block;
            font-size: 0.78rem;
            padding: 3px 10px;
            border-radius: 12px;
            background: #dcfce7;
            color: #166534;
            text-decoration: none;
            cursor: pointer;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toc-pill:hover {
            background: #bbf7d0;
        }

        .pheno-toc-pill .pill-count {
            font-weight: 600;
            margin-left: 2px;
        }

        .pheno-toggle-all {
            font-size: 0.78rem;
            color: #16a34a;
            cursor: pointer;
            background: none;
            border: 1px solid #bbf7d0;
            border-radius: 6px;
            padding: 3px 10px;
            margin-left: auto;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toggle-all:hover {
            background: #f0fdf4;
        }

        /* Collapsible category groups */
        .phenotype-category-group {
            margin-bottom: 2px;
        }

        .phenotype-category-group summary {
            font-size: 0.85rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #16a34a;
            margin: 0;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #bbf7d0;
            cursor: pointer;
            list-style: none;
            display: flex;
            align-items: center;
            gap: 6px;
        }

        .phenotype-category-group summary::-webkit-details-marker {
            display: none;
        }

        .phenotype-category-group summary .chevron {
            display: inline-block;
            width: 16px;
            height: 16px;
            transition: transform 0.15s;
            flex-shrink: 0;
        }

        .phenotype-category-group[open] summary .chevron {
            transform: rotate(90deg);
        }

        .phenotype-category-group summary .cat-count {
            font-size: 0.75rem;
            font-weight: 400;
            color: #15803d;
            background: #dcfce7;
            padding: 1px 7px;
            border-radius: 8px;
        }

        /* Phenotype Contexts */
        .phenotype-contexts {
            margin-top: 10px;
        }

        .phenotype-contexts-toggle {
            font-size: 0.8rem;
            color: var(--text-muted);
            cursor: pointer;
            user-select: none;
        }

        .phenotype-contexts-toggle:hover {
            color: var(--primary);
        }

        .context-card {
            padding: 10px 14px;
            margin-top: 8px;
            border-radius: 8px;
            background: #ecfdf5;
            border: 1px solid #a7f3d0;
            font-size: 0.88rem;
        }

        .context-header {
            display: flex;
            flex-wrap: wrap;
            align-items: center;
            gap: 6px;
            margin-bottom: 6px;
        }

        .context-label {
            font-size: 0.72rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            padding: 2px 8px;
            border-radius: 4px;
        }

        .context-label-genetic {
            background: #dbeafe;
            color: #1e40af;
        }

        .context-label-sex {
            background: #fce7f3;
            color: #9d174d;
        }

        .context-label-population {
            background: #fef3c7;
            color: #92400e;
        }

        .context-label-age {
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-label-subtype {
            background: #ede9fe;
            color: #5b21b6;
        }

        .context-label-frequency {
            background: #dcfce7;
            color: #166534;
        }

        .context-gene-list {
            display: flex;
            flex-wrap: wrap;
            gap: 4px;
            margin: 4px 0;
        }

        .context-gene-tag {
            font-size: 0.78rem;
            font-weight: 600;
            padding: 1px 8px;
            border-radius: 4px;
            background: #bfdbfe;
            color: #1e3a8a;
        }

        .context-detail {
            font-size: 0.84rem;
            color: #065f46;
            line-height: 1.5;
        }

        .context-detail strong {
            color: #047857;
        }

        .context-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #bbf7d0;
            color: #14532d;
            font-weight: 600;
        }

        .context-onset {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-severity {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #fef3c7;
            color: #92400e;
        }

        .context-notes {
            font-size: 0.84rem;
            color: #065f46;
            margin-top: 4px;
            line-height: 1.5;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        /* Clinical Trials */
        .clinical-trial-box {
            background: #f5f3ff;
            border-left: 4px solid #a855f7;
        }
        .clinical-trial-box .item-name { color: #6b21a8; }
        .clinical-trial-box .item-desc { color: #7e22ce; }

        .tag-phase {
            background: #ede9fe;
            color: #6b21a8;
        }

        .tag-status {
            background: #fce7f3;
            color: #9d174d;
        }

        .trial-nct a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .trial-nct a:hover {
            text-decoration: underline;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }
        .classification-header {
            font-size: 1rem;
            font-weight: 600;
            color: #4338ca;
            margin: 1.2rem 0 0.5rem 0;
            padding-bottom: 0.3rem;
            border-bottom: 2px solid #c7d2fe;
            text-transform: capitalize;
        }
        .subtype-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 0.4rem;
            margin: 0.3rem 0;
        }
        .subtype-freq-badge {
            background: #dbeafe;
            color: #1e40af;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-gene-tag {
            background: #fef3c7;
            color: #92400e;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-inheritance-tag {
            background: #ede9fe;
            color: #5b21b6;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-term-link {
            font-size: 0.8rem;
            color: #6366f1;
            text-decoration: none;
        }
        .subtype-term-link:hover { text-decoration: underline; }
        .subtype-children {
            margin: 0.4rem 0 0.2rem 1rem;
            padding: 0;
            list-style: none;
        }
        .subtype-children li {
            font-size: 0.85rem;
            color: #4338ca;
            padding: 0.1rem 0;
        }
        .subtype-children li::before {
            content: "↳ ";
            color: #a5b4fc;
        }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-link {
            text-decoration: none;
            color: inherit;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    <div class="notice-banner" role="button" tabindex="0">This resource is in its pre-alpha development stage. Content is actively being curated and may be incomplete or subject to change.</div>
    

    

    
    

    
    

    

    

    

    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Lyme Disease</span>
        </nav>

        <header class="page-header">
            <h1>Lyme Disease</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Infectious</span>
                
                
                <span class="badge badge-mondo">
                    <a href="http://purl.obolibrary.org/obo/MONDO_0019632" target="_blank">
                        MONDO:0019632
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Bacterial Infection</span>
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Tick-Borne Disease</span>
                
            </div>
            
            <p style="margin-top: 16px; font-size: 1rem; line-height: 1.6; opacity: 0.95; position: relative;">
                Lyme disease is a tick-borne infectious disease caused by Borrelia burgdorferi and related Borrelia species. It is the most common vector-borne disease in North America and Europe. The disease progresses through stages: early localized (erythema migrans), early disseminated (multiple erythema migrans, neurological, cardiac involvement), and late disseminated (arthritis, chronic neurological). Early antibiotic treatment is highly effective, while delayed treatment may lead to persistent symptoms.

            </p>
            
            
            <div class="header-dates">
                
                <span class="date-chip">
                    <span class="date-chip-label">Entry created</span>
                    <time datetime="2026-01-09T05:55:26Z">2026-01-09</time>
                </span>
                
                
                <span class="date-chip">
                    <span class="date-chip-label">Last updated</span>
                    <time datetime="2026-01-21T00:06:53Z">2026-01-21</time>
                </span>
                
            </div>
            
        </header>

        <!-- Stats bar -->
        
        
        
        
        
        
        
        
        
        
        
        
        
        <div class="stats-bar">
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Mappings</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Definitions</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Inheritance</div>
            </div>
            
            
            <a class="stat-link" href="#pathophysiology">
            <div class="stat-item">
                <div class="stat-value">3</div>
                <div class="stat-label">Pathophysiology</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Histopathology</div>
            </div>
            
            
            <a class="stat-link" href="#phenotypes">
            <div class="stat-item">
                <div class="stat-value">9</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#genetic">
            <div class="stat-item">
                <div class="stat-value">1</div>
                <div class="stat-label">Genes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#treatments">
            <div class="stat-item">
                <div class="stat-value">3</div>
                <div class="stat-label">Treatments</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#subtypes">
            <div class="stat-item">
                <div class="stat-value">4</div>
                <div class="stat-label">Subtypes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#differentials">
            <div class="stat-item">
                <div class="stat-value">7</div>
                <div class="stat-label">Differentials</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Datasets</div>
            </div>
            
            
            <a class="stat-link" href="#trials">
            <div class="stat-item">
                <div class="stat-value">3</div>
                <div class="stat-label">Trials</div>
            </div>
            </a>
            
        </div>

        <!-- Classifications -->
        

        <!-- Mappings -->
        

        <!-- Definitions -->
        

        <!-- Inheritance -->
        

        <!-- Subtypes -->
        
        <div class="card" id="subtypes">
            <div class="card-header">
                <div class="card-icon" style="background: #eef2ff; color: #4f46e5;">◆</div>
                <h2 class="card-title">Subtypes</h2>
                <span class="card-count">4</span>
            </div>
            
            
            
                
                
                    
                
                
            
                
                
                
            
                
                
                
            
                
                
                
            
            
                
                
                <div class="item-box subtype-box">
                    <div class="item-name">
                        Early Localized Lyme Disease
                        
                    </div>
                    <div class="subtype-meta">
                        
                        
                        
                    </div>
                    
                    <div class="item-desc">Initial stage within weeks of tick bite, characterized by erythema migrans and flu-like symptoms.</div>
                    
                    
                    
    
    
                </div>
                
                <div class="item-box subtype-box">
                    <div class="item-name">
                        Early Disseminated Lyme Disease
                        
                    </div>
                    <div class="subtype-meta">
                        
                        
                        
                    </div>
                    
                    <div class="item-desc">Hematogenous spread within weeks to months, with multiple erythema migrans, neurological, or cardiac involvement.</div>
                    
                    
                    
    
    
                </div>
                
                <div class="item-box subtype-box">
                    <div class="item-name">
                        Late Disseminated Lyme Disease
                        
                    </div>
                    <div class="subtype-meta">
                        
                        
                        
                    </div>
                    
                    <div class="item-desc">Months to years after infection, characterized by Lyme arthritis or chronic neurological manifestations.</div>
                    
                    
                    
    
    
                </div>
                
                <div class="item-box subtype-box">
                    <div class="item-name">
                        Post-Treatment Lyme Disease Syndrome
                        
                    </div>
                    <div class="subtype-meta">
                        
                        
                        
                    </div>
                    
                    <div class="item-desc">Persistent symptoms after appropriate antibiotic therapy, occurring in 10-20% of treated patients.</div>
                    
                    
                    
    
    
                </div>
                
            
        </div>
        

        <!-- Comorbidities -->
        

        <!-- Pathophysiology -->
        
        <div class="card" id="pathophysiology">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">⚙</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Spirochete Invasion and Dissemination</div>
                
                <div class="item-desc">Borrelia burgdorferi is transmitted through Ixodes tick bites. The spirochete disseminates from the skin through the bloodstream to multiple organ systems including joints, heart, and nervous system. Surface adhesins like BBK32 and decorin-binding proteins (DbpA/DbpB) facilitate tissue colonization.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        endothelial cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000115" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        cell adhesion
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0007155" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33669940" target="_blank">PMID:33669940</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The clinical manifestations of Lyme disease range from a localized infection, for example, erythema migrans (EM) to a disseminated neurological or rheumatological infection, cardiac involvement, or even chronic disease."</div>
                
                
                <div class="evidence-explanation">Epidemiologic series shows Borrelia disseminates beyond skin to neurologic, rheumatologic, and cardiac sites.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Autoimmune Activation after Persistent Infection</div>
                
                <div class="item-desc">Prolonged exposure of the host immune system to Borrelia antigens can drive post-infectious autoimmunity, with reported triggers of systemic autoimmune disease after Lyme borreliosis.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        T cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000084" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        immune system process
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0002376" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/34786243" target="_blank">PMID:34786243</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"long-term exposure of the host&#39;s immune system to spirochetes can contribute to the development of chronic autoimmune disease de novo."</div>
                
                
                <div class="evidence-explanation">Case review links persistent Borrelia exposure to downstream autoimmune disease.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Inflammatory Response and Tissue Damage</div>
                
                <div class="item-desc">The host immune response to Borrelia antigens contributes to tissue damage. Spirochetal lipoproteins and peptidoglycan trigger robust innate immune activation with production of IL-6, IL-8, TNF, and chemokines (CCL3/CCL4). Persistent inflammation in joints may continue even after spirochete clearance.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        neutrophil
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000775" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-cell">
                        macrophage
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000235" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-cell">
                        T cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000084" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        inflammatory response
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006954" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37407232" target="_blank">PMID:37407232</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Aspiration of the left knee joint revealed a white cell count of 21.0×109/L (83% neutrophils) with negative Gram stain and culture. However, Lyme PCR was positive and accompanied by serologies consistent with Lyme arthritis."</div>
                
                
                <div class="evidence-explanation">Lyme arthritis joint fluid shows marked neutrophilic inflammation despite negative cultures, consistent with immune-driven damage.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Histopathology -->
        

        <!-- Causal Graph -->
        

        <!-- Phenotypes -->
        
        <div class="card" id="phenotypes">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">●</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">9</span>
            </div>
            
            
            <div class="pheno-toc">
                
                <a class="pheno-toc-pill" data-target="pheno-cat-1">Cardiovascular<span class="pill-count">(2)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-2">Head and Neck<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-3">Immune<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-4">Integument<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-5">Musculoskeletal<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-6">Nervous System<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-7">Constitutional<span class="pill-count">(2)</span></a>
                
                <button class="pheno-toggle-all" id="phenoToggleAll">Expand all</button>
            </div>
            
            
            <details class="phenotype-category-group" id="pheno-cat-1">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Cardiovascular
                    <span class="cat-count">2</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Erythema Migrans
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0031180" target="_blank">
                                Erythema migrans
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0031180)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33669940" target="_blank">PMID:33669940</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Results: In total, 1005 patients were enrolled with the following prevalence of clinical syndromes: erythema migrans (EM), 945 (94.02%); Lyme arthritis, 32 (3.18%); neuroborreliosis, 23 (2.28%); Lyme carditis, 4 (0.39%); and acrodermatitis, 1 (0.09%)."</div>
                
                
                <div class="evidence-explanation">Large Lithuanian cohort confirms erythema migrans as the dominant presentation.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Atrioventricular Block
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001678" target="_blank">
                                Atrioventricular block
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001678)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37234726" target="_blank">PMID:37234726</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"the most common clinical manifestation is AV block, which can be acute in onset and can rapidly progress to complete heart block."</div>
                
                
                <div class="evidence-explanation">Case report and review emphasize AV block as the hallmark of Lyme carditis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-2">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Head and Neck
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Facial Palsy
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0010628" target="_blank">
                                Facial palsy
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0010628)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33669940" target="_blank">PMID:33669940</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The main symptoms were the following: nervus facialis neuropathy (47.8%), myalgia (39%), head pain (26%), and radiculitis (21%)."</div>
                
                
                <div class="evidence-explanation">Neuroborreliosis cases frequently manifested facial nerve palsy.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-3">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Immune
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Myelitis
                        
                        <span class="phenotype-freq">RARE</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0012486" target="_blank">
                                Myelitis
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0012486)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33082765" target="_blank">PMID:33082765</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"We report a case of acute neuroborreliosis that manifested as extended isolated cervical myelitis."</div>
                
                
                <div class="evidence-explanation">Case report confirms Lyme-associated cervical myelitis with CSF pleocytosis and intrathecal Borrelia antibodies.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-4">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Integument
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Bullous Skin Lesions
                        
                        <span class="phenotype-freq">RARE</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0033804" target="_blank">
                                Subepidermal blistering
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0033804)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41133080" target="_blank">PMID:41133080</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"developed acquired epidermolysis bullosa (EBA) following an LD diagnosis. Initially, the patient presented with atypical erythema migrans, which later evolved into multiple bullous lesions"</div>
                
                
                <div class="evidence-explanation">Case report documents bullous lesions evolving after Lyme disease.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-5">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Musculoskeletal
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Arthritis
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001369" target="_blank">
                                Arthritis
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001369)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33669940" target="_blank">PMID:33669940</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Lyme arthritis mainly manifested among middle-aged women as an oligoarthritis, mostly affecting the knee joint."</div>
                
                
                <div class="evidence-explanation">Cohort study documents oligoarticular knee-predominant Lyme arthritis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-6">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Nervous System
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Dementia (Reversible Neuroborreliosis)
                        
                        <span class="phenotype-freq">RARE</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000726" target="_blank">
                                Dementia
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000726)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30046879" target="_blank">PMID:30046879</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Dementia-like syndromes are rare manifestations of Lyme neuroborreliosis... The response to 2-4 weeks of antibiotic treatment with ceftriaxone was excellent."</div>
                
                
                <div class="evidence-explanation">Review of definite neuroborreliosis cases shows dementia syndromes resolving after ceftriaxone.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36740841" target="_blank">PMID:36740841</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Lyme disease is an uncommon cause of reversible dementia... the brilliant clinical improvement after the appropriate antimicrobial therapy is strongly suggestive for a diagnosis of neuroborreliosis."</div>
                
                
                <div class="evidence-explanation">Geriatric case of reversible dementia with marked improvement after antimicrobial therapy.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-7">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Constitutional
                    <span class="cat-count">2</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Fatigue
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0012378" target="_blank">
                                Fatigue
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0012378)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33669940" target="_blank">PMID:33669940</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Clinical symptoms were as follows: arthralgia (33.2%), general weakness (19%), head pain (13.1%), myalgia (11.2%), fever (6.2%), joint swelling (5.9%), head dizziness (5.1%), nervus facialis neuropathy (2.4%), and radiculitis (2.0%)."</div>
                
                
                <div class="evidence-explanation">Population data list general weakness among frequent symptoms of Lyme disease.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Arthralgia
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0002829" target="_blank">
                                Arthralgia
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0002829)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33669940" target="_blank">PMID:33669940</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Clinical symptoms were as follows: arthralgia (33.2%), general weakness (19%), head pain (13.1%), myalgia (11.2%), fever (6.2%), joint swelling (5.9%), head dizziness (5.1%), nervus facialis neuropathy (2.4%), and radiculitis (2.0%)."</div>
                
                
                <div class="evidence-explanation">Arthralgia was reported in one-third of patients in a large endemic cohort.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <script>
            (function() {
                // TOC pill click: expand target group and scroll to it
                document.querySelectorAll('.pheno-toc-pill').forEach(function(pill) {
                    pill.addEventListener('click', function() {
                        var target = document.getElementById(pill.dataset.target);
                        if (target) {
                            target.open = true;
                            target.scrollIntoView({behavior: 'smooth', block: 'start'});
                        }
                    });
                });
                // Expand/collapse all toggle
                var btn = document.getElementById('phenoToggleAll');
                if (btn) {
                    btn.addEventListener('click', function() {
                        var groups = document.querySelectorAll('.phenotype-category-group');
                        var anyOpen = Array.from(groups).some(function(g) { return g.open; });
                        groups.forEach(function(g) { g.open = !anyOpen; });
                        btn.textContent = anyOpen ? 'Expand all' : 'Collapse all';
                    });
                }
            })();
            </script>
            
        </div>
        

        <!-- Genetic Associations -->
        
        <div class="card" id="genetic">
            <div class="card-header">
                <div class="card-icon" style="background: #dbeafe; color: #2563eb;">🧬</div>
                <h2 class="card-title">Genetic Associations</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    HLA-DR4
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Susceptibility)</span>
                    
                </div>
                
                
    
    
            </div>
            
        </div>
        

        <!-- Treatments -->
        
        <div class="card" id="treatments">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">💊</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Oral Doxycycline
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">First-line treatment for early localized and early disseminated Lyme disease in adults. Typical dose is 100mg twice daily for 10-21 days. Also provides prophylaxis for tick bites in endemic areas.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/17029130" target="_blank">PMID:17029130</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Tables list the doses and durations of antimicrobial therapy recommended for treatment and prevention of Lyme disease"</div>
                
                
                <div class="evidence-explanation">IDSA guidelines provide evidence-based antibiotic treatment recommendations for Lyme disease.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Oral Amoxicillin
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Alternative first-line agent for early Lyme disease, preferred in children under 8 years and pregnant women. Typical dose is 500mg three times daily.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/17176487" target="_blank">PMID:17176487</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"We describe a favorable outcome in a 42-year-old woman who developed Lyme disease in the third trimester and was treated with a full course of oral amoxicillin."</div>
                
                
                <div class="evidence-explanation">Case report in pregnancy shows successful treatment with amoxicillin.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Intravenous Ceftriaxone
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Recommended for neurological Lyme disease (neuroborreliosis), Lyme carditis with high-degree AV block, and some cases of Lyme arthritis. Duration typically 14-28 days.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37692616" target="_blank">PMID:37692616</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The patient&#39;s symptoms resolved quickly with a four-day inpatient course of IV ceftriaxone followed by 10 days of oral doxycycline."</div>
                
                
                <div class="evidence-explanation">Neuroborreliosis case improved with intravenous ceftriaxone then doxycycline.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ccfbf1; color: #0d9488;">🌍</div>
                <h2 class="card-title">Environmental Factors</h2>
                <span class="card-count">5</span>
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Tick Exposure</div>
                
                <div class="item-desc">Ixodes scapularis (deer tick) in eastern North America, I. pacificus in western North America, I. ricinus in Europe</div>
                
                
                
    
    
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Geographic Location</div>
                
                <div class="item-desc">Endemic areas include northeastern and upper midwestern United States, and parts of Europe and Asia</div>
                
                
                
    
    
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Seasonal Exposure</div>
                
                <div class="item-desc">Peak transmission during late spring and summer months (May-August) when nymphal ticks are active</div>
                
                
                
    
    
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Outdoor Activities</div>
                
                <div class="item-desc">Risk factors include hiking, camping, gardening, and activities in wooded or grassy areas</div>
                
                
                
    
    
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Non-Ixodes Tick Exposure</div>
                
                <div class="item-desc">Rare reports of dog tick (Rhipicephalus) transmission in India; underscores need to consider atypical vectors in endemic settings</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36352974" target="_blank">PMID:36352974</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"we present the case of Lyme&#39;s disease in an adult male with dog tick, Rhipecephalus as a vector."</div>
                
                
                <div class="evidence-explanation">Case report documents Lyme transmission by Rhipicephalus dog tick, highlighting atypical vector risk.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Biochemical Markers -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">🔬</div>
                <h2 class="card-title">Biochemical Markers</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Anti-Borrelia Antibodies (IgM/IgG)
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Detected)</span>
                    
                </div>
                
                <div class="item-desc">Context: Two-tier testing with ELISA screening and Western blot confirmation; antibodies may take 2-4 weeks to develop</div>
                
                
    
    
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Elevated ESR/CRP
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Elevated)</span>
                    
                </div>
                
                <div class="item-desc">Context: Markers of systemic inflammation, especially in disseminated disease</div>
                
                
    
    
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    CSF Pleocytosis
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Elevated)</span>
                    
                </div>
                
                <div class="item-desc">Context: In neuroborreliosis, lymphocytic pleocytosis with elevated protein and intrathecal antibody production</div>
                
                
    
    
            </div>
            
        </div>
        

        <!-- Differential Diagnoses -->
        
        <div class="card" id="differentials">
            <div class="card-header">
                <div class="card-icon" style="background: #fef2f2; color: #dc2626;">🔀</div>
                <h2 class="card-title">Differential Diagnoses</h2>
                <span class="card-count">7</span>
            </div>
            <p style="margin-bottom: 16px; font-size: 0.95rem; color: var(--text-muted);">
                Conditions with similar clinical presentations that must be differentiated from Lyme Disease:
            </p>
            
            <div class="item-box differential-box">
                <div class="item-name">
                    Southern Tick-Associated Rash Illness (STARI)
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/MONDO_0025294" target="_blank">
                            MONDO:0025294
                        </a>
                    </span>
                    
                </div>
                
                <div class="differential-similarities">
                    <strong>Overlapping Features</strong>
                    Lone star tick-associated erythema migrans–like rash without Borrelia burgdorferi infection.
                </div>
                
                
                <div class="differential-distinctions">
                    <strong>Distinguishing Features</strong>
                    
                    <ul>
                        
                        <li>Occurs after Amblyomma americanum bite in southeastern/south-central US; Borrelia testing negative.</li>
                        
                        <li>Typically lacks systemic neurologic or cardiac involvement seen in disseminated Lyme.</li>
                        
                    </ul>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/40788480" target="_blank">PMID:40788480</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Southern tick-associated rash illness (STARI)"</div>
                
                
                <div class="evidence-explanation">Highlights STARI as a distinct erythema migrans–like illness linked to lone star tick bites.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box differential-box">
                <div class="item-name">
                    Cellulitis
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/MONDO_0005230" target="_blank">
                            MONDO:0005230
                        </a>
                    </span>
                    
                </div>
                
                <div class="differential-similarities">
                    <strong>Overlapping Features</strong>
                    Bacterial skin infection that can mimic early erythema migrans.
                </div>
                
                
                <div class="differential-distinctions">
                    <strong>Distinguishing Features</strong>
                    
                    <ul>
                        
                        <li>Painful, warm, expanding erythema often with fever.</li>
                        
                        <li>No central clearing.</li>
                        
                        <li>Responds rapidly to anti-staphylococcal/streptococcal therapy.</li>
                        
                    </ul>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/26437159" target="_blank">PMID:26437159</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"atypical vesicular features... resulted in multiple misdiagnoses and delayed treatment"</div>
                
                
                <div class="evidence-explanation">Atypical erythema migrans presentations can be misdiagnosed as bacterial cellulitis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box differential-box">
                <div class="item-name">
                    Septic Arthritis
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/MONDO_0042485" target="_blank">
                            MONDO:0042485
                        </a>
                    </span>
                    
                </div>
                
                <div class="differential-similarities">
                    <strong>Overlapping Features</strong>
                    Acute bacterial arthritis of large joints.
                </div>
                
                
                <div class="differential-distinctions">
                    <strong>Distinguishing Features</strong>
                    
                    <ul>
                        
                        <li>Very high synovial WBC with positive Gram stain/culture.</li>
                        
                        <li>Lacks migratory arthralgias and Borrelia serology.</li>
                        
                        <li>Requires urgent drainage.</li>
                        
                    </ul>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/24028811" target="_blank">PMID:24028811</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"clinical and biological picture often resembles that of septic arthritis"</div>
                
                
                <div class="evidence-explanation">Pediatric Lyme arthritis cases can initially be confused with septic arthritis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box differential-box">
                <div class="item-name">
                    Rheumatoid Arthritis
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/MONDO_0008383" target="_blank">
                            MONDO:0008383
                        </a>
                    </span>
                    
                </div>
                
                <div class="differential-similarities">
                    <strong>Overlapping Features</strong>
                    Chronic symmetric inflammatory polyarthritis.
                </div>
                
                
                <div class="differential-distinctions">
                    <strong>Distinguishing Features</strong>
                    
                    <ul>
                        
                        <li>Small-joint symmetric involvement with RF/anti-CCP positivity.</li>
                        
                        <li>No tick exposure history or erythema migrans.</li>
                        
                        <li>Nodules and erosions on imaging.</li>
                        
                    </ul>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/24028811" target="_blank">PMID:24028811</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"clinical and biological picture often resembles that of septic arthritis and juvenile rheumatoid arthritis"</div>
                
                
                <div class="evidence-explanation">Lyme arthritis may mimic rheumatoid patterns, prompting serologic differentiation.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box differential-box">
                <div class="item-name">
                    Viral Encephalitis
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/MONDO_0006009" target="_blank">
                            MONDO:0006009
                        </a>
                    </span>
                    
                </div>
                
                <div class="differential-similarities">
                    <strong>Overlapping Features</strong>
                    CNS infection causing encephalopathy that can overlap with neuroborreliosis symptoms.
                </div>
                
                
                <div class="differential-distinctions">
                    <strong>Distinguishing Features</strong>
                    
                    <ul>
                        
                        <li>CSF PCR panels for HSV/VZV/arboviruses.</li>
                        
                        <li>Absent Borrelia intrathecal antibodies.</li>
                        
                        <li>Often acute febrile onset.</li>
                        
                    </ul>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/29848409" target="_blank">PMID:29848409</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Two serum samples from one patient showed neutralizing antibodies against TBE virus."</div>
                
                
                <div class="evidence-explanation">Tick-borne encephalitis virus infection was found in a patient initially suspected of Lyme, illustrating viral encephalitis as a key differential.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box differential-box">
                <div class="item-name">
                    Multiple Sclerosis and Other Demyelinating Myelopathies
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/MONDO_0005301" target="_blank">
                            MONDO:0005301
                        </a>
                    </span>
                    
                </div>
                
                <div class="differential-similarities">
                    <strong>Overlapping Features</strong>
                    Demyelinating CNS disease that can mimic neuroborreliosis with cord lesions.
                </div>
                
                
                <div class="differential-distinctions">
                    <strong>Distinguishing Features</strong>
                    
                    <ul>
                        
                        <li>Oligoclonal bands without intrathecal Borrelia antibodies.</li>
                        
                        <li>Typical MS lesion distribution.</li>
                        
                        <li>Relapsing course without tick exposure.</li>
                        
                    </ul>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/34861197" target="_blank">PMID:34861197</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"examples... newly diagnosed included multiple sclerosis"</div>
                
                
                <div class="evidence-explanation">Cohort of presumed Lyme referrals identified multiple sclerosis as a frequent alternate diagnosis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box differential-box">
                <div class="item-name">
                    Viral Myocarditis/Other Causes of AV Block
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/MONDO_0004496" target="_blank">
                            MONDO:0004496
                        </a>
                    </span>
                    
                </div>
                
                <div class="differential-similarities">
                    <strong>Overlapping Features</strong>
                    Cardiac conduction disease from viral myocarditis or idiopathic fibrosis.
                </div>
                
                
                <div class="differential-distinctions">
                    <strong>Distinguishing Features</strong>
                    
                    <ul>
                        
                        <li>Elevated cardiac biomarkers and viral serologies.</li>
                        
                        <li>Absence of erythema migrans or Lyme serology.</li>
                        
                        <li>Persistent AV block without rapid reversal on antibiotics.</li>
                        
                    </ul>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/40385752" target="_blank">PMID:40385752</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Comprehensive investigations excluded other bradyarrhythmia causes, such as Lyme disease, sarcoidosis, and myocarditis"</div>
                
                
                <div class="evidence-explanation">Case of dengue-related complete heart block underscores non-Lyme infectious causes of advanced AV block.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Datasets -->
        

        <!-- Clinical Trials -->
        
        <div class="card" id="trials">
            <div class="card-header">
                <div class="card-icon" style="background: #f5f3ff; color: #a855f7;">🔬</div>
                <h2 class="card-title">Clinical Trials</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box clinical-trial-box">
                <div class="item-name">
                    NCT03769194
                    
                    <span class="tag tag-phase">PHASE_II</span>
                    
                    
                    <span class="tag tag-status">COMPLETED</span>
                    
                </div>
                
                <div class="item-desc">Randomized, controlled, observer-blind Phase 2 study evaluating immunogenicity and safety of VLA15, a multivalent recombinant OspA-based Lyme borreliosis vaccine candidate in healthy adults aged 18-65 years. Participants received 3 immunizations at monthly intervals.</div>
                
                
                <div class="item-meta">
                    <strong style="font-size: 0.8rem; color: #6b21a8;">Target Phenotypes:</strong>
                    
                    <span class="tag" style="background: #ede9fe; color: #6b21a8; font-size: 0.8rem;">
                        Erythema migrans
                        
                        <a href="http://purl.obolibrary.org/obo/HP_0031180" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://clinicaltrials.gov/study/NCT03769194" target="_blank">clinicaltrials:NCT03769194</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The study was investigated 3 doses of a multivalent OspA (Outer Surface Protein A) based Lyme vaccine (VLA15) in healthy adults aged 18 to 65 years of age. Study participants received 3 immunizations of the vaccine at a monthly interval."</div>
                
                
                <div class="evidence-explanation">This Phase 2 trial evaluates VLA15, a preventive vaccine targeting OspA surface protein, offering evidence for active immunization against Lyme borreliosis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box clinical-trial-box">
                <div class="item-name">
                    NCT06785402
                    
                    <span class="tag tag-phase">PHASE_II</span>
                    
                    
                    <span class="tag tag-status">RECRUITING</span>
                    
                </div>
                
                <div class="item-desc">Randomized, double-blind, placebo-controlled Phase 1/2 trial evaluating pulse-dosed intravenous ceftriaxone for Post-Treatment Lyme Disease Syndrome (PTLDS). Investigates whether periodic high-dose antibiotic therapy can eliminate persistent Borrelia burgdorferi in patients with persistent symptoms.</div>
                
                
                <div class="item-meta">
                    <strong style="font-size: 0.8rem; color: #6b21a8;">Target Phenotypes:</strong>
                    
                    <span class="tag" style="background: #ede9fe; color: #6b21a8; font-size: 0.8rem;">
                        Fatigue
                        
                        <a href="http://purl.obolibrary.org/obo/HP_0012378" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                    <span class="tag" style="background: #ede9fe; color: #6b21a8; font-size: 0.8rem;">
                        Arthralgia
                        
                        <a href="http://purl.obolibrary.org/obo/HP_0002829" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://clinicaltrials.gov/study/NCT06785402" target="_blank">clinicaltrials:NCT06785402</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Lyme disease is a public health crisis in the US. It is estimated that over 400,000 cases occur every year with 10-20% of those infected going on to develop Post-Treatment Lyme disease Syndrome (PTLDS). The goal of this study is to investigate if giving Ceftriaxone every 5 days for about 6 weeks..."</div>
                
                
                <div class="evidence-explanation">This Phase 1/2 trial directly addresses post-treatment Lyme disease syndrome with a novel pulse-dosing regimen, providing clinical evidence for managing antibiotic-refractory cases.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box clinical-trial-box">
                <div class="item-name">
                    NCT03584919
                    
                    <span class="tag tag-phase">NOT_APPLICABLE</span>
                    
                    
                    <span class="tag tag-status">COMPLETED</span>
                    
                </div>
                
                <div class="item-desc">European prospective clinical trial comparing doxycycline and cefuroxime axetil for treatment of erythema migrans in adult patients. Participants were evaluated at baseline, 14 days, and 2, 6, and 12 months post-enrollment to assess treatment efficacy and long-term outcomes.</div>
                
                
                <div class="item-meta">
                    <strong style="font-size: 0.8rem; color: #6b21a8;">Target Phenotypes:</strong>
                    
                    <span class="tag" style="background: #ede9fe; color: #6b21a8; font-size: 0.8rem;">
                        Erythema migrans
                        
                        <a href="http://purl.obolibrary.org/obo/HP_0031180" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://clinicaltrials.gov/study/NCT03584919" target="_blank">clinicaltrials:NCT03584919</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"A European, prospective clinical trial in which doxycycline and cefuroxime axetil were compared in the treatment of adult patients with erythema migrans included a control group to address this question. Evaluations of patients were conducted at baseline, 14 days and 2, 6, and 12 months after enrollment."</div>
                
                
                <div class="evidence-explanation">This comparative trial evaluates two oral antibiotics for early Lyme disease, providing evidence for treatment options and long-term symptom outcomes in erythema migrans patients.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Lyme Disease
creation_date: &#39;2026-01-09T05:55:26Z&#39;
updated_date: &#39;2026-01-21T00:06:53Z&#39;
category: Infectious
description: &gt;
  Lyme disease is a tick-borne infectious disease caused by Borrelia burgdorferi
  and related Borrelia species. It is the most common vector-borne disease in
  North America and Europe. The disease progresses through stages: early localized
  (erythema migrans), early disseminated (multiple erythema migrans, neurological,
  cardiac involvement), and late disseminated (arthritis, chronic neurological).
  Early antibiotic treatment is highly effective, while delayed treatment may lead
  to persistent symptoms.
disease_term:
  preferred_term: Lyme disease
  term:
    id: MONDO:0019632
    label: Lyme disease
parents:
- Bacterial Infection
- Tick-Borne Disease
has_subtypes:
- name: Early Localized Lyme Disease
  description: Initial stage within weeks of tick bite, characterized by erythema migrans and flu-like symptoms.
- name: Early Disseminated Lyme Disease
  description: Hematogenous spread within weeks to months, with multiple erythema migrans, neurological, or cardiac involvement.
- name: Late Disseminated Lyme Disease
  description: Months to years after infection, characterized by Lyme arthritis or chronic neurological manifestations.
- name: Post-Treatment Lyme Disease Syndrome
  description: Persistent symptoms after appropriate antibiotic therapy, occurring in 10-20% of treated patients.
pathophysiology:
- name: Spirochete Invasion and Dissemination
  description: &gt;
    Borrelia burgdorferi is transmitted through Ixodes tick bites. The spirochete
    disseminates from the skin through the bloodstream to multiple organ systems
    including joints, heart, and nervous system. Surface adhesins like BBK32 and
    decorin-binding proteins (DbpA/DbpB) facilitate tissue colonization.
  evidence:
  - reference: PMID:33669940
    supports: SUPPORT
    snippet: &#34;The clinical manifestations of Lyme disease range from a localized infection, for example, erythema migrans (EM) to a disseminated neurological or rheumatological infection, cardiac involvement, or even chronic disease.&#34;
    explanation: Epidemiologic series shows Borrelia disseminates beyond skin to neurologic, rheumatologic, and cardiac sites.
  cell_types:
  - preferred_term: endothelial cell
    term:
      id: CL:0000115
      label: endothelial cell
  biological_processes:
  - preferred_term: cell adhesion
    term:
      id: GO:0007155
      label: cell adhesion
- name: Autoimmune Activation after Persistent Infection
  description: &gt;
    Prolonged exposure of the host immune system to Borrelia antigens can drive
    post-infectious autoimmunity, with reported triggers of systemic autoimmune
    disease after Lyme borreliosis.
  evidence:
  - reference: PMID:34786243
    supports: SUPPORT
    snippet: &#34;long-term exposure of the host&#39;s immune system to spirochetes can contribute to the development of chronic autoimmune disease de novo.&#34;
    explanation: Case review links persistent Borrelia exposure to downstream autoimmune disease.
  cell_types:
  - preferred_term: T cell
    term:
      id: CL:0000084
      label: T cell
  biological_processes:
  - preferred_term: immune system process
    term:
      id: GO:0002376
      label: immune system process
- name: Inflammatory Response and Tissue Damage
  description: &gt;
    The host immune response to Borrelia antigens contributes to tissue damage.
    Spirochetal lipoproteins and peptidoglycan trigger robust innate immune
    activation with production of IL-6, IL-8, TNF, and chemokines (CCL3/CCL4).
    Persistent inflammation in joints may continue even after spirochete clearance.
  evidence:
  - reference: PMID:37407232
    supports: SUPPORT
    snippet: &#34;Aspiration of the left knee joint revealed a white cell count of 21.0×109/L (83% neutrophils) with negative Gram stain and culture. However, Lyme PCR was positive and accompanied by serologies consistent with Lyme arthritis.&#34;
    explanation: Lyme arthritis joint fluid shows marked neutrophilic inflammation despite negative cultures, consistent with immune-driven damage.
  cell_types:
  - preferred_term: neutrophil
    term:
      id: CL:0000775
      label: neutrophil
  - preferred_term: macrophage
    term:
      id: CL:0000235
      label: macrophage
  - preferred_term: T cell
    term:
      id: CL:0000084
      label: T cell
  biological_processes:
  - preferred_term: inflammatory response
    term:
      id: GO:0006954
      label: inflammatory response
phenotypes:
- name: Erythema Migrans
  category: Dermatologic
  frequency: VERY_FREQUENT
  description: Characteristic expanding circular rash at the site of tick bite, often with central clearing (bull&#39;s-eye appearance). Present in 70-80% of cases.
  phenotype_term:
    preferred_term: Erythema migrans
    term:
      id: HP:0031180
      label: Erythema migrans
  evidence:
  - reference: PMID:33669940
    supports: SUPPORT
    snippet: &#34;Results: In total, 1005 patients were enrolled with the following prevalence of clinical syndromes: erythema migrans (EM), 945 (94.02%); Lyme arthritis, 32 (3.18%); neuroborreliosis, 23 (2.28%); Lyme carditis, 4 (0.39%); and acrodermatitis, 1 (0.09%).&#34;
    explanation: Large Lithuanian cohort confirms erythema migrans as the dominant presentation.
- name: Fatigue
  category: Constitutional
  frequency: VERY_FREQUENT
  description: Profound fatigue is common in all stages of Lyme disease and may persist in post-treatment Lyme disease syndrome.
  phenotype_term:
    preferred_term: Fatigue
    term:
      id: HP:0012378
      label: Fatigue
  evidence:
  - reference: PMID:33669940
    supports: SUPPORT
    snippet: &#34;Clinical symptoms were as follows: arthralgia (33.2%), general weakness (19%), head pain (13.1%), myalgia (11.2%), fever (6.2%), joint swelling (5.9%), head dizziness (5.1%), nervus facialis neuropathy (2.4%), and radiculitis (2.0%).&#34;
    explanation: Population data list general weakness among frequent symptoms of Lyme disease.
- name: Arthralgia
  category: Musculoskeletal
  frequency: FREQUENT
  description: Joint pain, particularly affecting large joints such as the knee, commonly precedes frank arthritis.
  phenotype_term:
    preferred_term: Arthralgia
    term:
      id: HP:0002829
      label: Arthralgia
  evidence:
  - reference: PMID:33669940
    supports: SUPPORT
    snippet: &#34;Clinical symptoms were as follows: arthralgia (33.2%), general weakness (19%), head pain (13.1%), myalgia (11.2%), fever (6.2%), joint swelling (5.9%), head dizziness (5.1%), nervus facialis neuropathy (2.4%), and radiculitis (2.0%).&#34;
    explanation: Arthralgia was reported in one-third of patients in a large endemic cohort.
- name: Facial Palsy
  category: Neurological
  frequency: OCCASIONAL
  description: Unilateral or bilateral facial nerve palsy (Bell&#39;s palsy) in early disseminated disease, occurring in approximately 5% of untreated patients.
  phenotype_term:
    preferred_term: Facial palsy
    term:
      id: HP:0010628
      label: Facial palsy
  evidence:
  - reference: PMID:33669940
    supports: SUPPORT
    snippet: &#34;The main symptoms were the following: nervus facialis neuropathy (47.8%), myalgia (39%), head pain (26%), and radiculitis (21%).&#34;
    explanation: Neuroborreliosis cases frequently manifested facial nerve palsy.
- name: Arthritis
  category: Musculoskeletal
  frequency: FREQUENT
  description: Inflammatory arthritis, typically monoarticular or oligoarticular, affecting large joints especially the knee. Occurs in approximately 60% of untreated patients.
  phenotype_term:
    preferred_term: Arthritis
    term:
      id: HP:0001369
      label: Arthritis
  evidence:
  - reference: PMID:33669940
    supports: SUPPORT
    snippet: &#34;Lyme arthritis mainly manifested among middle-aged women as an oligoarthritis, mostly affecting the knee joint.&#34;
    explanation: Cohort study documents oligoarticular knee-predominant Lyme arthritis.
- name: Atrioventricular Block
  category: Cardiac
  frequency: OCCASIONAL
  description: Cardiac involvement including AV block (first, second, or third degree) and myocarditis. Lyme carditis occurs in 1-5% of untreated patients.
  phenotype_term:
    preferred_term: Atrioventricular block
    term:
      id: HP:0001678
      label: Atrioventricular block
  evidence:
  - reference: PMID:37234726
    supports: SUPPORT
    snippet: &#34;the most common clinical manifestation is AV block, which can be acute in onset and can rapidly progress to complete heart block.&#34;
    explanation: Case report and review emphasize AV block as the hallmark of Lyme carditis.
- name: Dementia (Reversible Neuroborreliosis)
  category: Neurological
  frequency: RARE
  description: Subcortical or reversible dementia presentations of neuroborreliosis that improve with antibiotic therapy.
  phenotype_term:
    preferred_term: Dementia
    term:
      id: HP:0000726
      label: Dementia
  evidence:
  - reference: PMID:30046879
    supports: SUPPORT
    snippet: &#34;Dementia-like syndromes are rare manifestations of Lyme neuroborreliosis... The response to 2-4 weeks of antibiotic treatment with ceftriaxone was excellent.&#34;
    explanation: Review of definite neuroborreliosis cases shows dementia syndromes resolving after ceftriaxone.
  - reference: PMID:36740841
    supports: SUPPORT
    snippet: &#34;Lyme disease is an uncommon cause of reversible dementia... the brilliant clinical improvement after the appropriate antimicrobial therapy is strongly suggestive for a diagnosis of neuroborreliosis.&#34;
    explanation: Geriatric case of reversible dementia with marked improvement after antimicrobial therapy.
- name: Myelitis
  category: Neurological
  frequency: RARE
  description: Inflammatory spinal cord involvement as a rare manifestation of acute neuroborreliosis, sometimes with mild clinical symptoms despite marked MRI edema.
  phenotype_term:
    preferred_term: Myelitis
    term:
      id: HP:0012486
      label: Myelitis
  evidence:
  - reference: PMID:33082765
    supports: SUPPORT
    snippet: &#34;We report a case of acute neuroborreliosis that manifested as extended isolated cervical myelitis.&#34;
    explanation: Case report confirms Lyme-associated cervical myelitis with CSF pleocytosis and intrathecal Borrelia antibodies.
- name: Bullous Skin Lesions
  category: Dermatologic
  frequency: RARE
  description: Autoimmune blistering lesions (epidermolysis bullosa acquisita-like) following Lyme infection; reported after atypical erythema migrans.
  phenotype_term:
    preferred_term: Subepidermal blistering
    term:
      id: HP:0033804
      label: Subepidermal blistering
  evidence:
  - reference: PMID:41133080
    supports: SUPPORT
    snippet: &#34;developed acquired epidermolysis bullosa (EBA) following an LD diagnosis. Initially, the patient presented with atypical erythema migrans, which later evolved into multiple bullous lesions&#34;
    explanation: Case report documents bullous lesions evolving after Lyme disease.
biochemical:
- name: Anti-Borrelia Antibodies (IgM/IgG)
  presence: Detected
  context: Two-tier testing with ELISA screening and Western blot confirmation; antibodies may take 2-4 weeks to develop
- name: Elevated ESR/CRP
  presence: Elevated
  context: Markers of systemic inflammation, especially in disseminated disease
- name: CSF Pleocytosis
  presence: Elevated
  context: In neuroborreliosis, lymphocytic pleocytosis with elevated protein and intrathecal antibody production
genetic:
- name: HLA-DR4
  association: Susceptibility
  notes: HLA-DRB1*04 alleles associated with antibiotic-refractory Lyme arthritis and autoimmune mechanisms
environmental:
- name: Tick Exposure
  notes: Ixodes scapularis (deer tick) in eastern North America, I. pacificus in western North America, I. ricinus in Europe
- name: Geographic Location
  notes: Endemic areas include northeastern and upper midwestern United States, and parts of Europe and Asia
- name: Seasonal Exposure
  notes: Peak transmission during late spring and summer months (May-August) when nymphal ticks are active
- name: Outdoor Activities
  notes: Risk factors include hiking, camping, gardening, and activities in wooded or grassy areas
- name: Non-Ixodes Tick Exposure
  notes: Rare reports of dog tick (Rhipicephalus) transmission in India; underscores need to consider atypical vectors in endemic settings
  evidence:
  - reference: PMID:36352974
    supports: SUPPORT
    snippet: &#34;we present the case of Lyme&#39;s disease in an adult male with dog tick, Rhipecephalus as a vector.&#34;
    explanation: Case report documents Lyme transmission by Rhipicephalus dog tick, highlighting atypical vector risk.
treatments:
- name: Oral Doxycycline
  description: &gt;
    First-line treatment for early localized and early disseminated Lyme disease
    in adults. Typical dose is 100mg twice daily for 10-21 days. Also provides
    prophylaxis for tick bites in endemic areas.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
  evidence:
  - reference: PMID:17029130
    supports: SUPPORT
    snippet: &#34;Tables list the doses and durations of antimicrobial therapy recommended for treatment and prevention of Lyme disease&#34;
    explanation: IDSA guidelines provide evidence-based antibiotic treatment recommendations for Lyme disease.
- name: Oral Amoxicillin
  description: &gt;
    Alternative first-line agent for early Lyme disease, preferred in children
    under 8 years and pregnant women. Typical dose is 500mg three times daily.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
  evidence:
  - reference: PMID:17176487
    supports: SUPPORT
    snippet: &#34;We describe a favorable outcome in a 42-year-old woman who developed Lyme disease in the third trimester and was treated with a full course of oral amoxicillin.&#34;
    explanation: Case report in pregnancy shows successful treatment with amoxicillin.
- name: Intravenous Ceftriaxone
  description: &gt;
    Recommended for neurological Lyme disease (neuroborreliosis), Lyme carditis
    with high-degree AV block, and some cases of Lyme arthritis. Duration
    typically 14-28 days.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
  evidence:
  - reference: PMID:37692616
    supports: SUPPORT
    snippet: &#34;The patient&#39;s symptoms resolved quickly with a four-day inpatient course of IV ceftriaxone followed by 10 days of oral doxycycline.&#34;
    explanation: Neuroborreliosis case improved with intravenous ceftriaxone then doxycycline.
differential_diagnoses:
- name: Southern Tick-Associated Rash Illness (STARI)
  disease_term:
    preferred_term: Southern Tick-Associated Rash Illness
    term:
      id: MONDO:0025294
      label: tick-borne infectious disease
  description: Lone star tick-associated erythema migrans–like rash without Borrelia burgdorferi infection.
  distinguishing_features:
  - Occurs after Amblyomma americanum bite in southeastern/south-central US; Borrelia testing negative.
  - Typically lacks systemic neurologic or cardiac involvement seen in disseminated Lyme.
  evidence:
  - reference: PMID:40788480
    supports: SUPPORT
    snippet: &#34;Southern tick-associated rash illness (STARI)&#34;
    explanation: Highlights STARI as a distinct erythema migrans–like illness linked to lone star tick bites.
- name: Cellulitis
  disease_term:
    preferred_term: cellulitis
    term:
      id: MONDO:0005230
      label: cellulitis
  description: Bacterial skin infection that can mimic early erythema migrans.
  distinguishing_features:
  - Painful, warm, expanding erythema often with fever.
  - No central clearing.
  - Responds rapidly to anti-staphylococcal/streptococcal therapy.
  evidence:
  - reference: PMID:26437159
    supports: SUPPORT
    snippet: &#34;atypical vesicular features... resulted in multiple misdiagnoses and delayed treatment&#34;
    explanation: Atypical erythema migrans presentations can be misdiagnosed as bacterial cellulitis.
- name: Septic Arthritis
  disease_term:
    preferred_term: infective arthritis
    term:
      id: MONDO:0042485
      label: infective arthritis
  description: Acute bacterial arthritis of large joints.
  distinguishing_features:
  - Very high synovial WBC with positive Gram stain/culture.
  - Lacks migratory arthralgias and Borrelia serology.
  - Requires urgent drainage.
  evidence:
  - reference: PMID:24028811
    supports: SUPPORT
    snippet: &#34;clinical and biological picture often resembles that of septic arthritis&#34;
    explanation: Pediatric Lyme arthritis cases can initially be confused with septic arthritis.
- name: Rheumatoid Arthritis
  disease_term:
    preferred_term: rheumatoid arthritis
    term:
      id: MONDO:0008383
      label: rheumatoid arthritis
  description: Chronic symmetric inflammatory polyarthritis.
  distinguishing_features:
  - Small-joint symmetric involvement with RF/anti-CCP positivity.
  - No tick exposure history or erythema migrans.
  - Nodules and erosions on imaging.
  evidence:
  - reference: PMID:24028811
    supports: SUPPORT
    snippet: &#34;clinical and biological picture often resembles that of septic arthritis and juvenile rheumatoid arthritis&#34;
    explanation: Lyme arthritis may mimic rheumatoid patterns, prompting serologic differentiation.
- name: Viral Encephalitis
  disease_term:
    preferred_term: viral encephalitis
    term:
      id: MONDO:0006009
      label: viral encephalitis
  description: CNS infection causing encephalopathy that can overlap with neuroborreliosis symptoms.
  distinguishing_features:
  - CSF PCR panels for HSV/VZV/arboviruses.
  - Absent Borrelia intrathecal antibodies.
  - Often acute febrile onset.
  evidence:
  - reference: PMID:29848409
    supports: SUPPORT
    snippet: &#34;Two serum samples from one patient showed neutralizing antibodies against TBE virus.&#34;
    explanation: Tick-borne encephalitis virus infection was found in a patient initially suspected of Lyme, illustrating viral encephalitis as a key differential.
- name: Multiple Sclerosis and Other Demyelinating Myelopathies
  disease_term:
    preferred_term: multiple sclerosis
    term:
      id: MONDO:0005301
      label: multiple sclerosis
  description: Demyelinating CNS disease that can mimic neuroborreliosis with cord lesions.
  distinguishing_features:
  - Oligoclonal bands without intrathecal Borrelia antibodies.
  - Typical MS lesion distribution.
  - Relapsing course without tick exposure.
  evidence:
  - reference: PMID:34861197
    supports: SUPPORT
    snippet: &#34;examples... newly diagnosed included multiple sclerosis&#34;
    explanation: Cohort of presumed Lyme referrals identified multiple sclerosis as a frequent alternate diagnosis.
- name: Viral Myocarditis/Other Causes of AV Block
  disease_term:
    preferred_term: myocarditis
    term:
      id: MONDO:0004496
      label: myocarditis
  description: Cardiac conduction disease from viral myocarditis or idiopathic fibrosis.
  distinguishing_features:
  - Elevated cardiac biomarkers and viral serologies.
  - Absence of erythema migrans or Lyme serology.
  - Persistent AV block without rapid reversal on antibiotics.
  evidence:
  - reference: PMID:40385752
    supports: SUPPORT
    snippet: &#34;Comprehensive investigations excluded other bradyarrhythmia causes, such as Lyme disease, sarcoidosis, and myocarditis&#34;
    explanation: Case of dengue-related complete heart block underscores non-Lyme infectious causes of advanced AV block.
clinical_trials:
- name: NCT03769194
  phase: PHASE_II
  status: COMPLETED
  description: Randomized, controlled, observer-blind Phase 2 study evaluating immunogenicity and safety of VLA15, a multivalent recombinant OspA-based Lyme borreliosis vaccine candidate in healthy adults aged 18-65 years. Participants received 3 immunizations at monthly intervals.
  target_phenotypes:
  - preferred_term: Erythema migrans
    term:
      id: HP:0031180
      label: Erythema migrans
  evidence:
  - reference: clinicaltrials:NCT03769194
    supports: SUPPORT
    snippet: &#34;The study was investigated 3 doses of a multivalent OspA (Outer Surface Protein A) based Lyme vaccine (VLA15) in healthy adults aged 18 to 65 years of age. Study participants received 3 immunizations of the vaccine at a monthly interval.&#34;
    explanation: This Phase 2 trial evaluates VLA15, a preventive vaccine targeting OspA surface protein, offering evidence for active immunization against Lyme borreliosis.
- name: NCT06785402
  phase: PHASE_II
  status: RECRUITING
  description: Randomized, double-blind, placebo-controlled Phase 1/2 trial evaluating pulse-dosed intravenous ceftriaxone for Post-Treatment Lyme Disease Syndrome (PTLDS). Investigates whether periodic high-dose antibiotic therapy can eliminate persistent Borrelia burgdorferi in patients with persistent symptoms.
  target_phenotypes:
  - preferred_term: Fatigue
    term:
      id: HP:0012378
      label: Fatigue
  - preferred_term: Arthralgia
    term:
      id: HP:0002829
      label: Arthralgia
  evidence:
  - reference: clinicaltrials:NCT06785402
    supports: SUPPORT
    snippet: &#34;Lyme disease is a public health crisis in the US. It is estimated that over 400,000 cases occur every year with 10-20% of those infected going on to develop Post-Treatment Lyme disease Syndrome (PTLDS). The goal of this study is to investigate if giving Ceftriaxone every 5 days for about 6 weeks kills the organism that produces persistent Lyme infection.&#34;
    explanation: This Phase 1/2 trial directly addresses post-treatment Lyme disease syndrome with a novel pulse-dosing regimen, providing clinical evidence for managing antibiotic-refractory cases.
- name: NCT03584919
  phase: NOT_APPLICABLE
  status: COMPLETED
  description: European prospective clinical trial comparing doxycycline and cefuroxime axetil for treatment of erythema migrans in adult patients. Participants were evaluated at baseline, 14 days, and 2, 6, and 12 months post-enrollment to assess treatment efficacy and long-term outcomes.
  target_phenotypes:
  - preferred_term: Erythema migrans
    term:
      id: HP:0031180
      label: Erythema migrans
  evidence:
  - reference: clinicaltrials:NCT03584919
    supports: SUPPORT
    snippet: &#34;A European, prospective clinical trial in which doxycycline and cefuroxime axetil were compared in the treatment of adult patients with erythema migrans included a control group to address this question. Evaluations of patients were conducted at baseline, 14 days and 2, 6, and 12 months after enrollment.&#34;
    explanation: This comparative trial evaluates two oral antibiotics for early Lyme disease, providing evidence for treatment options and long-term symptom outcomes in erythema migrans patients.
datasets:
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/Lyme_Disease.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
    <script>
        (function() {
            const banner = document.querySelector('.notice-banner');
            if (!banner) return;
            const dismiss = () => banner.remove();
            banner.addEventListener('click', dismiss);
            banner.addEventListener('keydown', (event) => {
                if (event.key === 'Enter' || event.key === ' ') {
                    event.preventDefault();
                    dismiss();
                }
            });
        })();
    </script>
</body>
</html>